Andrea Newkirk
Stock Analyst at Goldman Sachs
(1.48)
# 3,484
Out of 5,002 analysts
5
Total ratings
33.33%
Success rate
3.26%
Average return
Main Sectors:
Stocks Rated by Andrea Newkirk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Initiates: Neutral | $19 | $21.20 | -10.38% | 1 | Sep 30, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $73 | $45.96 | +58.83% | 2 | Sep 12, 2025 | |
| ALKS Alkermes | Initiates: Buy | $43 | $31.08 | +38.35% | 1 | Jul 15, 2025 | |
| ETNB 89bio | Initiates: Neutral | $11 | $14.85 | -25.93% | 1 | Mar 14, 2025 |
Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $21.20
Upside: -10.38%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65 → $73
Current: $45.96
Upside: +58.83%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $31.08
Upside: +38.35%
89bio
Mar 14, 2025
Initiates: Neutral
Price Target: $11
Current: $14.85
Upside: -25.93%